MDI-2517

N/A

Report date: 2024/06/17 14:25:14
NME

Base Information

Drug NameMDI-2517
Drug Alias NameMDI-2517
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen activator inhibitor 1 inhibitors
TargetsPlasminogen activator inhibitor 1
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMDI Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMDI Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A